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MISLEADING PREMIUM CLAIMS 
Stephen Corones * 
One powerful way for suppliers of goods to distinguish their product from those of their 
competitors and thereby establish consumer preferences is to make a premium claim in 
relation to them. Premium claims (sometimes referred to as credence claims) involve a 
representation of a premium or special quality that differentiates one product from another. 
It may be difficult for consumers to verify these claims. Suppliers who make premium claims 
for their goods will generally spend on advertising and selling to convey this information to 
consumers. If the supplier succeeds in influencing the tastes of consumers that its product is 
better or superior in some way to those of its competitors that will allow it to charge a 
premium price. Where such claims are false they result not only in consumer detriment, but 
also harm existing competitors by taking away market share and creating an artificial 
barrier to new entry. Since 2013, the Australian Competition and Consumer Commission 
(ACCC) has significantly increased its enforcement activity in relation to false or misleading 
premium claims. This article examines these developments.  
I INTRODUCTION 
While the ACCC has pursued false premium claims especially in relation to food products 
over many years, in 2013 it announced that it would be treating premium claims more 
generally as an enforcement priority.
1
 Premium claims have remained an enforcement 
priority for the ACCC since 2013.
2
 According to the ACCC: 
Premium claims may suggest a product is safer (‘non-toxic’), offers a moral or 
social benefit (‘free range eggs’) or a nutritional benefit (‘fat free’). The 
benefit may also be 'green' or environmental (‘100% recyclable’) or 
therapeutic (‘the fastest pain reliever’). A premium claim may also promote a 
product as being of a perceived quality (‘Swiss chocolate’ or ‘Belgian 
beer’).Claims that give the impression that a product, or one of its attributes, 
has some kind of added benefit when compared to similar products and 
services can be made as long as the claims are not misleading and can be 
substantiated.3 
                                                            
*Professor, Centre for Commercial and Property Law, Faculty of Law, Queensland University of Technology. 
1 Sims R, “Championing the rights of consumers” a speech delivered at the National Consumer Congress on 15 
March 2013 at the Swissotel, Sydney. Available at http://www.accc.gov.au/about-us/conferences-
events/national-consumer-congress/national-consumer-congress-2013 
2 See ACCC Compliance and Enforcement Policy (February 2015), p 4. 
3 ACCC,  False or misleading claims.  Available at: http://www.accc.gov.au/business/advertising-promoting-
your-business/false-or-misleading-claims  
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Premium claims may contravene the general and specific consumer protection provisions in 
Chapters 2 and 3 of the Australian Consumer Law (ACL) located in Schedule 2 of the 
Competition and Consumer Act 2010 (Cth) (CCA) and adopted in the States and Territories 
as a law of their respective jurisdictions.
4
 Sections 18 and 29(1)(a) and (g) of the ACL, 
prohibit the making of false or misleading representations that goods have a particular quality 
or a particular history or particular performance characteristics. They may also contravene s 
33 of the ACL which prohibits conduct liable to mislead the public as to the nature or 
characteristics of goods. It should be noted, however, that the nature or characteristics of 
goods refer to their “…internal constitution or utility rather than the manner of their 
creation”.5 While there may be some scope for overlap this will not always be the case. The 
general and specific consumer protection provisions in Chapters 2 and 3 of the ACL mirror 
those contained in Part V of the former Trade Practices Act 1974 (Cth) (TPA), and the case 
law interpreting the TPA provisions is applicable to the equivalent provisions in the ACL. 
The structure of this article is to consider first the policy objects of the CCA in relation to 
premium claims. Part three examines how the courts establish whether a premium claim is 
misleading for the purposes of the general and specific protections in the ACL. Part four 
examines ACCC’s discretionary administrative powers in relation to premium claims. 
Finally, Part five discusses some recent cases in which the ACCC has sought the imposition 
of civil sanctions in the courts.  
II POLICY OBJECTS 
Where markets are characterised by high levels of competition they automatically produce 
efficient outcomes in terms of lower costs, improved product quality, greater innovation and 
higher productivity.
6
 Competition forces suppliers to satisfy consumer preferences and 
increase choices for consumers. However, in some cases competition alone will not deter 
suppliers from making misleading claims in relation to their products. While consumers may 
be able to use their own experiences to evaluate whether a claim is accurate through normal 
use, they may not be able to do so in the case of a premium claim. They may not be able to 
test whether consuming a product reduces the risk of heart disease because of information 
asymmetries. Where false premium claims are difficult to detect because of information 
asymmetries, an unscrupulous supplier who makes a false premium claim will mislead 
consumers into buying its product. Where premium claims are false they are a source not 
only of consumer detriment, but also result in lost sales to the suppliers of genuine products. 
On the supply side premium claims are the result of innovation and can promote competitive 
rivalry. False premium claims can deter suppliers from engaging in innovation, because 
consumers will be cynical in future about the accuracy of such claims. 
                                                            
4        See Fair Trading Act 1987  (NSW) , ss 27 and 28 ;  Australian Consumer Law and Fair Trading Act 2012  
(Vic), ss 7 and 8 ;  Fair Trading Act 1989  (Qld), ss 15 and 16 ;  Fair Trading Act 2010  (WA), ss 18 and 
19 ;  Fair Trading Act 1987  (SA), ss 13 and 14 ;  Australian Consumer Law (Tasmania) Act 2010  (Tas), 
ss 5 and 6 ;  Consumer Affairs and Fair Trading Act  (NT), ss 26 and 27 ; and  Fair Trading (Australian 
Consumer Law) Act 1992  (ACT), ss 6 and 7. 
5 ACCC v Turi Foods Pty Ltd (No 4) (2013) ATPR ¶42-448 at [127] (Tracey J). 
6 See Productivity Commission, Review of Australia’s Consumer Policy Framework (Final Report, 2008 
Canberra), Vol 2, ch 3. See also OECD, Consumer Policy Toolkit (OECD, Paris, 2010), Ch 2 and OECD, Roundtable 
on Demand-side Economics for Consumer Policy, Summary Report  20 April 2006 (OECD Paris), available at 
http://www.oecd.org. 
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The “consumer protection” provisions of the TPA were concerned with the supply side 
(competition in markets) as well as protecting consumers on the demand side. Misleading 
premium claims give rise to market efficiency considerations because of the effect of the 
conduct on other competitors. Lockhart J recognised this in Colgate-Palmolive Pty Ltd v 
Rexona Pty Ltd,
7
 and granted an interlocutory injunction to prevent a misleading premium 
claim by Rexona concerning the effectiveness of Aim toothpaste for the following reasons: 
In my opinion the possible detriment to the small manufacturers is a relevant 
consideration. The Act is concerned with the maintenance of free and healthy 
competition. If a corporation is engaging in misleading or deceptive 
advertising which assists it in gaining a substantial share of a market at the 
expense of small manufacturers, the interests of those manufacturers must be a 
relevant consideration when considering the balance of convenience.
8
 
In assessing the level of pecuniary penalties to be imposed under s 224 of the ACL for 
misleading premium claims, the court is required to take into account the amount of the loss 
or damage caused by the conduct to consumers on the demand side and competitors on the 
supply side. For example, in ACCC v Reebok Australia Pty Ltd , McKerracher J stated: 
The damage to fair and open competition in the footwear market in Australia cannot 
be quantified, but it is likely that the conduct had a significant effect because some 
consumers were misled into purchasing the EasyTone shoes on the basis of credence 
attributes which they could not readily verify, and where they would not otherwise 
have made such a purchase had they known the shoes did not have such attributes.
9
   
III CONTRAVENTION OF ss 18, 29(1)(a), (g) and (k) AND 33 OF THE ACL 
This part examines how the courts establish whether a premium claim is misleading for the 
purposes of the general and specific protections in the ACL. The general protection in s 18 of 
the ACL provides that: 
A person must not, in trade or commerce, engage in conduct that is misleading 
or deceptive or is likely to mislead of deceive. 
The specific protection in s 29(1) of the ACL provides that: 
A person must not, in trade or commerce, in connection with the supply or 
possible supply of goods or services or in connection with the promotion by 
any means of the supply or use of goods or services: 
(a) make a false or misleading representation that goods are of a particular 
standard, quality, value, grade, composition, style or model or have had a 
                                                            
7 Colgate-Palmolive Pty Ltd v Rexona Pty Ltd  (1981) ATPR ¶40-242 . 
8 Colgate-Palmolive Pty Ltd v Rexona Pty Ltd (1981) ATPR ¶40-242 at 43,194-43,195. See also  Janssen-Cilag 
Pty Limited v Pfizer Pty Limited  (1992) ATPR ¶41-186 (Lockhart J). 
9 ACCC v Reebok Australia Pty Ltd [2015] FCA 83 at [143] citing the Full Federal Court in 
Singtel Optus Pty Ltd v ACCC (2012) 287 ALR 249 at [69]. 
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particular history or particular previous use; or 
… 
(g) make a false or misleading representation that goods or services have 
sponsorship, approval, performance characteristics, accessories, uses or 
benefits; or 
… 
(k) make a false or misleading representation concerning the place of 
origin of goods 
The specific protection in s33 of the ACL provides that: 
A person must not, in trade or commerce, engage in conduct that is liable to 
mislead the public as to the nature, the manufacturing process, the 
characteristics, the suitability for their purpose or the quantity of any goods. 
There is scope for overlap between ss 18, 29(1)(a), (g) and (k), and 33 of the ACL.
10
 
Many premium claims will be directed at the public at large, or a segment of the public, 
rather than at a particular individual. The test to be applied in establishing whether conduct is 
misleading, or likely to mislead, for the purposes of ss 18 and 29 is for the court to assess 
what the effect of the claim is likely to be on a reasonable member of the class. In Parkdale 
Custom Built Furniture Pty Ltd v Puxu Pty Ltd, Gibbs CJ stated: 
Although it is true, as has often been said, that ordinarily a class of consumers may 
include the inexperienced as well as the experienced, and the gullible as well as the 
astute, the section must in my opinion by [sic] regarded as contemplating the effect of 
the conduct on reasonable members of the class. The heavy burdens which the section 
creates cannot have been intended to be imposed for the benefit of persons who fail to 
take reasonable care of their own interests.
11
 
These principles were confirmed by the High Court in Campomar Sociedad Limitada v Nike 
International Ltd (‘Campomar’): 
It is in these cases of representations to the public … that there enter the ‘ordinary’ or 
‘reasonable’ members of the class of prospective purchasers. Although a class of 
consumers may be expected to include a wide range of persons, in isolating the 
‘ordinary’ or ‘reasonable’ members of that class, there is an objective attribution of 
certain characteristics.
12
 
Intention was not a necessary element of the contravention of s 52 of the TPA. The section 
involved no questions of intent upon the part of the person whose conduct was in question. 
Thus, in Google Inc v ACCC , French CJ and Crennan and Kiefel JJ noted that “s 52 is not 
                                                            
10 See ACCC v Pirovic Enterprises Pty Ltd (No 2) (2014) ATPR ¶42-483 (Flick J) and ACCC v R L Adams Pty 
Ltd [2015] FCA 1016 (Edelman J). 
 11 Parkdale Custom Built Furniture Pty Ltd v Puxu Pty Ltd(1982) 149 CLR 191, 199. See also Miller & 
Associates Insurance Broking Pty Ltd v BMW Australia Finance Ltd (2010) 241 CLR 357, 371 [22] (French CJ 
and Kiefel J). 
 12Campomar Sociedad Limitada v Nike International Ltd (2000) 202 CLR 45, 85 [102] (Gleeson CJ, 
Gaudron, McHugh, Gummow, Kirby, Hayne and Callinan JJ) (citations omitted). 
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confined to conduct which is intended to mislead or deceive. A corporation could contravene 
s 52 even though it acted reasonably and honestly”.13 In Butcher v Lachlan Elder Realty Pty 
Ltd, McHugh J stated: “Section 52 looks at the conduct of a corporation and is concerned 
only with whether that conduct misled or was likely to mislead a consumer. It is not 
concerned with the mental state of the corporation”.14 
However, intention is not entirely irrelevant. In Campomar v Nike the trial judge, Sheppard J, 
found that Campomar deliberately marketed the Nike Sports Fragrance products in order to 
take advantage of the goodwill and reputation of Nike International.
15
 The High Court held, 
where there is a finding of intention to deceive, the Court may more readily infer that the 
intention has been or in all probability will be, effective.
16 
The same approach applies in relation to s 18 of the ACL. Conduct may be found to 
contravene s 18 of the ACL even though the respondent acted honestly and did not intend to 
mislead or deceive. On the other hand, where the respondent did intend to mislead or deceive, 
a court may more readily find that the conduct was misleading or likely to mislead.
17
 
In Australian Competition and Consumer Commission v TPG Internet Pty Ltd, the High Court 
majority stated:  
[W]here a representation is made in terms apt to create a particular 
mental impression in the representee, and is intended to do so, it may 
properly be inferred that it has that effect.  Such an inference may be 
drawn more readily where the business of the representor is to make 
such representations and where the representor’s business benefits 
from creating such an impression.
18
 
                                                            
13 Google Inc v ACCC (2013) 249 CLR 435 at 443. See also Hornsby Building Information Centre Pty Ltd v 
Sydney building Information Centre Ltd (1978) 140 CLR 216 at 228, (Stephen J) and Parkdale Custom Built 
Furniture Pty Ltd v Puxu Pty Ltd  (1982) 149 CLR 191 at 197, (Gibbs CJ). 
 
14 Butcher v Lachlan Elder Realty Pty Ltd,(2004) 218 CLR 592 at 634 [139] citing Hill J in Equity Access Pty 
Ltd v Westpac Banking Corporation :‘‘Section 52 is not confined to conduct which is intended to mislead or 
deceive . . . and a corporation which acts honestly and reasonably may none the less engage in conduct that is 
likely to mislead or deceive.’’ 
15 Nike International Ltd v Campomar Sociedad Limitada  (1996) ATPR ¶41-518 at 42,478, 42,480. 
16 Campomar Sociedad Limitada v Nike International Ltd  (2000) 202 CLR 45 at [33] (Gleeson CJ, Gaudron, 
McHugh, Gummow, Kirby, Hayne and Callinan JJ). This principle has been applied in subsequent cases. 
See, eg,  ACCC v Singtel Optus Pty Ltd (No 3)  (2010) 276 ALR 102 where Perram J inferred that Optus 
intended its misleading advertising campaign to have a substantial impact in the broadband market, based 
on the amount of money which Optus spent on the campaign, and concluded that the effect of the 
campaign was substantial (at [16]-[17]). 
17 S & I Publishing Pty Ltd v Australian Surf Life Saver Pty Ltd  (1998) 88 FCR 354 at 361-363 (Hill, RD 
Nicholson and Emmett JJ). 
18 ACCC v TPG Internet Pty Ltd (2013) 304 ALR 189, 198 [55] (French CJ, Crennan, Bell and Keane JJ) 
(Citations omitted). 
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The issue in ACCC v TPG was the effectiveness of small print elucidators to clarify a bold 
headline statement in a television advertisement. This will depend on the all the surrounding 
circumstances but especially the medium used to convey the advertisement, and whether it 
allows a reasonable member of the target audience the opportunity to carefully consider the 
advertisement or statement in its entirety.  
The use of small print elucidators to correct premium claims concerning the nutritional 
benefits of food products on packaging and in television commercials has arisen in a number 
of ACCC investigations. Where food manufacturers make premium claims about the health 
benefits of their products must be able to substantiate the claim by means of scientific testing 
based on recent data. For example, on 23 November 2015, the ACCC issued five 
infringement notices on Arnott’s Biscuits Ltd (Arnott’s) for claiming that Shapes Light & 
Crispy products had 75 per cent less saturated fat, but the comparison was made with potato 
chips cooked in palm oil rather than original Shapes. This was included in a small print 
elucidator at the bottom of the packs, but the ACCC had reasonable grounds to believe that 
the representation was still misleading and not based on a meaningful comparison for 
consumers.
19
 
Similarly, on 26 November 2015 the ACCC issued infringement notices on Cereal Partners 
Australia Pty Ltd (CPA) because it had reasonable grounds to believe that CPA made false or 
misleading claims concerning the protein content of certain Uncle Tobys brand oats products. 
The packaging of Uncle Tobys ‘Quick Sachets’ oats stated that they were a ‘Natural Source 
of Protein* Superfood. The product packaging contained a small print elucidator ‘*when 
prepared with skim milk’, which appeared in fine print below the word ‘protein’ prominently 
in the centre of the front of the package in a bright colour and a large font size. The ACCC 
alleged that the small print elucidator was not adequate to correct the misleading dominant 
message ‘protein superfood’.20 
In some cases premium claims are made by representors who know that the representations 
cannot be supported, and who also know that the target audience will not be able to check the 
accuracy of the claim because of the information asymmetry between the maker of the 
representation and the audience. In such cases, intention and deliberateness will be taken into 
account in deciding whether the conduct was misleading and the size of the penalty that 
should be imposed. 
In cases involving information asymmetry, or where representors hold themselves out as 
having specialist knowledge or expertise, the court may find that a reasonable member of the 
target audience may conclude that the representation conveyed not merely that the maker 
believed the claim, but also that there were reasonable grounds for that belief, or, in the case 
of scientific or medical claims, that there was an adequate scientific or medical basis for the 
claim. If there is no adequate basis to substantiate the claim it will be found to be misleading. 
In ACCC v Breast Check Pty Ltd,
21
 Breast Check published promotional pamphlets stating 
that its thermography devices for conducting breast imaging could be used for assessing 
whether a customer was at risk from breast cancer and the level of that risk. The ACCC also 
                                                            
19 ACCC Media Release, MR 229/15 (23 November 2015). 
20 ACCC Media Release, MR 233/15 (26 November 2015). 
21 ACCC v Breast Check Pty Ltd (2014) ATPR 42-479. 
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alleged that Breast Check’s claim contained representation that there was an adequate 
scientific basis for using the thermography devices as a substitute for mammography. It was 
held that Breast Check had contravened s 53(c) of the TPA and s 29(1)(g) of the ACL. Barker 
J found: 
In the context of a representation of a medical nature … it would be entirely 
reasonable for a consumer to conclude that, where a service of a medical nature is 
being provided, there would be scientific medical evidence of a sufficient quality to 
support the use of the equipment used to provide such a service and that the use of 
breast imaging devices would not be promoted in a way as to be contrary to the state 
of scientific medical knowledge.
22
  
What constitutes an “adequate” basis was considered by Barker J who stated: 
 
As to the question of the representation conveying that there is an adequate scientific 
or medical basis, I accept the submission made on behalf of ACCC that the word 
“adequate” should be taken in the sense by which it is generally understood. In the 
medical context that is that the service is provided according to evidence based 
medical knowledge and that there is sufficient support in medical science for the use 
of the devices for the purposes represented. This is particularly so in the context of 
assessing whether or not a person may have or be at risk of breast cancer, which is 
clearly a question of medical science.
23
  
In some cases a premium claim will be demonstrably false and it will not be necessary to 
consider whether it conveyed a representation that there was a reasonable basis for making 
the claim. For example, in Australian Competition and Consumer Commission v Apple Pty 
Limited,
24
 the ACCC alleged that Apple's promotion of the "iPad with WiFi + 4G" was 
misleading because it represented to Australian consumers that the product "iPad with WiFi + 
4G" could, with a SIM card, connect to a 4G mobile data network in Australia, when this was 
not the case. The ACCC alleged that Apple's conduct contravened ss 18, 29(1)(a), 29(1)(g) 
and 33 of the ACL. It was conceded that the use of the product designator "iPad with WiFi + 
4G" contravened s 33 because it represented that the new iPad cellular model could connect 
to the Telstra LTE mobile data network when this was not the case. The word “characteristic” 
in s 33 included the operational capacity of the goods.  
The equivalent provision in the TPA was s 55, the meaning of which was considered in in 
ACCC v Turi Foods Pty Ltd (No 4).
25
 The ACCC brought proceedings against Baiada Poultry 
                                                            
22 ACCC v Breast Check Pty Ltd (2014) ATPR ¶42-479 at [141]. 
23 ACCC v Breast Check Pty Ltd (2014) ATPR 42-479 at [139]. There is a line of authority that supports this 
approach. See Global Sportsman v Mirror Newspapers (1984) 2 FCR 82 at 88 (Bowen CJ, Lockhart and 
Fitzgerald JJ); James v Australia and New Zealand Banking Group Ltd  (1986) 64 ALR 347 at 372 
(Toohey J); Wright v Wheeler Grace & Pierucci Pty Ltd  (1988) ATPR ¶40-865 at 49,375-49,376 
(French J); affirmed in  Wheeler Grace & Pierucci Pty Ltd v Wright  (1989) 16 IPR 189; Bateman v 
Slayter  (1987) 71 ALR 553 at 559 (Burchett J); and Thompson v Ice Creameries of Australia Pty Ltd  
(1998) ATPR ¶41-611 at 40,693 (Lehane J). Cf Forrest v ASIC (2012) 247 CLR 486, 525 [103] (Heydon 
J). 
24 ACCC v Apple Pty Limited (2012) ATPR ¶42-404 (Bromberg J). 
25 ACCC v Turi Foods Pty Ltd (No 4) (2013) ATPR ¶42-448. 
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Pty Ltd and Bartter Enterprises Pty Ltd which supplied chickens nationally under the 
Steggles brand, Turi Foods which supplied La Ionica brand meat chickens in NSW and 
Victoria and the Australian Chicken Meat Federation Inc. The ACCC alleged that Baiada 
Poultry and Bartter Enterprises made false or misleading claims in print advertising and 
product packaging, that Steggles meat chickens are raised in barns with substantial space 
available allowing them to roam freely. Tracey J held: 
In the context of s 55 the nature and characteristics of goods are to be identified by 
reference to their internal constitution or utility rather than the manner of their 
creation.  Section 55 will thus be contravened, for example, if it is represented that 
35% of liquid in a container is fruit juice when the truth is that juice comprised only 
17% of the contents.
26
 
Since the “free to roam” representations did not relate to the inherent qualities of the 
chickens, but rather to the circumstances in which the chickens were raised, the ACCC’s 
allegation of a contravention of s55 was not made out. The remainder of this part will 
consider some of the kinds of premium claims that have been the subject of ACCC 
enforcement. 
A Moral or social benefit 
The ACCC has been particularly active in relation to claims involving the use of the term 
“free range” in connection with food products.27 In ACCC v Turi Foods Pty Ltd (No 4) it was 
held that a representation that chickens were “free to roam in large barns” was held to 
contravene ss 52 and 53(a) of the TPA (the TPA equivalents of ss 18 and 29(1)(a) of the 
ACL), because the representation was likely to mislead consumers as to the circumstances in 
which the chickens had been raised or grown by falsely representing that the chickens had a 
particular history of being raised or grown in barns in which they were “free to roam”.28 
However, the “free to roam” representation did not relate to the inherent qualities of the 
chickens and so they did not contravene s 55 of the TPA.
29
 Tracey J observed: 
There was … no evidence to link those circumstances with any inherent quality such 
as taste or fat content of any processed chickens which were marketed by producers or 
processors.
30
 
In ACCC v Pirovic Enterprises Pty Ltd (No 2),
31
 Pirovic admitted that it had infringed ss18, 
29(1)(a) and 33 of the ACL by marketing as “free range” eggs produced by hens that were 
farmed in conditions that allowed the hens to live in large barns and roam freely on green 
pastures during the day, returning indoors at night, when this was not the case.  
                                                            
26 ACCC v Turi Foods Pty Ltd (No 4) (2013) ATPR ¶42-448 at [127]. 
27 In October 2015 the ACCC released its Enforcement Guidance in relation to Free Range Hen Egg Claims 
available athttp://www.accc.gov.au/system/files/1029_Free%20range%20Eggs%20guidelines_FA.pdf 
28 ACCC v Turi Foods Pty Ltd (No 4) (2013) ATPR ¶42-448 at [114]. 
29 ACCC v Turi Foods Pty Ltd (No 4) (2013) ATPR ¶42-448 at [129]. 
30 ACCC v Turi Foods Pty Ltd (No 4) (2013) ATPR ¶42-448 at [128]. 
31 ACCC v Pirovic Enterprises Pty Ltd (No 2) (2014) ATPR ¶42-483. 
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Pirovic’s labels complied with the labelling guide produced by the industry body, the 
Australian Egg Corporation Limited (AECL). Pirovic’s farms had an “A” level accreditation 
for free range egg production, and the NSW Food Authority  had deemed the AECL scheme  
to be compliant with the Primary Industries Standing Committee’s Model Code of Practice 
for the Welfare of Animals – Domestic Poultry. This, however, was not the test to be applied 
for the purposes of ss18, 29(1)(a) and 33 of the ACL.  
Pirovic admitted that the labels were misleading and amounted to a contravention of s18 
because the message they conveyed to a reasonable member of the target audience did not 
comply with the conditions in which the laying hens were kept. Pirovic also admitted that the 
conduct amounted to a contravention of s 29(1)(a) because it was likely to mislead the public 
as to the quality and history of the eggs supplied, and a contravention of s 33 because it was 
likely to mislead the public as to the nature and characteristics of its eggs. 
B Nutritional benefit 
Premium claims such as “fresh”, “100 per cent freshly squeezed orange juice”, “totally fat 
free”, “no added colours or preservatives”, and “free from additives”, in relation to food and 
beverages can be used to justify higher prices and create a competitive advantage for a 
supplier. Standard 1.2.7 of the Australia New Zealand Food Standards Code sets put the 
requirements to be met for the use of nutritional and health claims in relation to certain 
foods.
32
 
In ACCC v Coles Supermarkets Australia Pty Limited, 
33
 the respondent supplied bread 
through its supermarkets. The bread was partially baked and frozen off-site by a supplier and 
‘finished’ at its in-house bakeries in its supermarkets. The bread was promoted as being 
‘Baked Today, sold Today’ and in some cases ‘Freshly Baked In-Store’. The Court found that 
the ‘Baked Today, sold Today’ and ‘Freshly Baked In-Store’ claims made by Coles 
amounted to a misleading representation that the partially baked bread had been baked on the 
day of sale or baked in a fresh process using fresh and not frozen product.  
C Environmental or organic benefit 
Consumers’ purchasing decisions may be influenced by energy savings claims, both in 
relation to the environmental benefits and to cost savings. On 8 February 2008, the ACCC 
published its guide, Green Marketing and the Trade Practices Act.
34
 In relation to 
environmental claims, the ACCC states: 
Those most relevant to environmental claims are: 
 Sponsorship – this connotes some form of backing by another party. The 
unauthorised use of a trademark may breach this provision. 
 Approval – this provision is mainly used when a business claims to have 
approval from a government agency or licensing board for its products, 
                                                            
32 Available at https://www.comlaw.gov.au/Details/F2015C00756 
33 ACCC v Coles Supermarkets Australia Pty Limited [2014] FCA 634. 
34 ACCC, Green Marketing and the Trade Practices Act (2008), available at 
http://www.accc.gov.au/content/index.phtml/itemId/815763 . 
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when no such approval has been given. 
 Performance characteristics – companies should not falsely claim that their 
goods or services have certain capabilities or effects they do not have. 
 Benefits – companies should not claim that a particular good or service has 
certain environmental benefits if these claims cannot be substantiated.
35
 
The Green Marketing Guide provides interpretations by the ACCC through definitions and 
illustrative examples. General environmental claims such as “green”, “environmentally 
friendly”, “eco-friendly” or “environmentally safe”, “energy efficient”, “recyclable”, “carbon 
neutral”, “renewable” or “green” energy, may be problematic.36 
For example, Samsung Electronics Australia Pty Ltd provided the ACCC with a court 
enforceable undertaking under s 87B of Act. The ACCC considered that Samsung 
representations that its Bubble Wash washing machines when using cold water offered 
considerable energy savings when compared with conventional washing machines using cold 
water.
37
 
In ACCC v G.O.Drew Pty Ltd,
38
 the respondent supplied eggs to retailers in packaging which 
stated that the eggs were ‘organic’, ‘organic free range’ and ‘Certified Organic by NASAA’ 
(the National Association for Sustainable Agriculture Australia). It was unable to obtain 
sufficient quantities of organic eggs so it substituted eggs that were not organic. The 
respondent consented to orders that it had engaged in misleading conduct contrary to s 52 of 
the TPA; had contravened s 53(a) by making a false or misleading representation that the 
goods were of a particular standard, quality, value, grade or composition which they were 
not; and contravened s 55 by making a representation that was liable to mislead the public as 
to the nature and characteristics of goods. The respondent agreed to pay $270,000 for 
distribution to the Organic Federation of Australia and NASAA. 
In July 2013 the ACCC succeeded in getting eight manufacturers of bottled water to remove 
the word “organic” from their labels. The ACCC stated: 
There is no support among Australian authorities for the notion that water can be 
organic and a number of standards state that it cannot, including the mandatory 
standard covering exports. The word ‘organic’ in the context of food and drink refers 
to agricultural products which have been farmed according to certain practices. Water 
is not an agricultural product, and cannot benefit from such practices so it is not 
appropriate to use ‘organic to describe it.39 
The Australian Standard (AS) 6000-2009 Organic and biodynamic products 
40
sets put the 
                                                            
35 ACCC, Green Marketing and the Trade Practices Act (2008), p 5. 
36 ACCC, Green Marketing and the Trade Practices Act (2008), pp 12-14. 
37 ACCC Media release MR 006/13 (21 January 2013). 
38 ACCC v G.O.Drew Pty Ltd [2007] FCA 1246. 
39 ACCC Media release NR 165/13 (16 July 2013). 
40 See the Standards Australia website www.standards.org.au 
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requirements to be met by growers and manufacturers who label their food products ‘organic’ 
or ‘biodynamic’. 
D Country or place of origin benefit 
Many consumers make purchasing decisions based on where a product was grown or 
produced because this may directly affect the quality of the product. Food products such as 
wine and cheese are often packaged and promoted on the basis that they emanate from a 
particular place which has a reputation for producing high quality products because of its 
climate or soil characteristics. Consumers are prepared to pay a premium for such goods. 
Some consumers have a preference for locally produced goods in order to support local 
employment. False or misleading representations concerning the place of origin of goods are 
prohibited by s 29(1)(k).  The equivalent provision of the TPA was s 53(eb). 
In ACCC v Marksun Australia Pty Ltd ,
41
 the respondent operated a business over the internet 
of selling a product described as “Ugg Boots from Australia” when in fact they were 
manufactured in China. The respondent also made use of the Australian Made Logo. This 
was held to be part of a deliberate marketing strategy in contravention of  ss 18 and 29(1)(k) 
of the ACL and a pecuniary penalty of $330,000 was imposed for the Made in Australia 
conduct and $100,000 for use of the Australian Made Logo conduct. Gilmour J observed that 
the conduct resulted not just in consumer detriment, but also harmed competitors who sold 
genuine Australian made boots.
42
 
 The country of origin provisions set out in Ch 5, Pt 5-3 of the ACL provide a series of ‘safe 
harbour’ defences  concerning the use of particular claims on the labels of goods. Thus, if it is 
alleged that a country of origin claim is misleading the person seeking to rely on the defence 
must establish that: 
(a) it was substantially transformed in the country in question and 
(b) 50 per cent or more of the total cost of producing or manufacturing the goods took 
place in that country.
43
 
If goods satisfy these defences a person is deemed by s 255 of the ACL not to have engaged 
in misleading or deceptive conduct or made a false or misleading representation under ss 18, 
29(1)(a), 29(1)(k), 151(1)(a) or 151(1)(k) of the ACL. If a supplier is unable to establish a 
‘safe harbour’ defence, its claim will be assessed against the likelihood it would be regarded 
as false or misleading or deceptive by ordinary and reasonable consumers. 
A place of origin representation is any labelling, packaging, logo or advertising that makes a 
statement or claim about the particular place from which the goods originated. On 19 August 
2014, the ACCC terminated its investigation into conduct by Maggie Beer Products Pty Ltd, 
a leading producer of gourmet food products, following the giving of a court enforceable 
undertaking pursuant to s 87B of the CCA. Maggie Beer Products made a representation on 
certain “Maggie Beer” branded products through the use of the Maggie Beer logo, the words 
“Maggie Beer A Barossa Food Tradition”, and the words “Maggie Beer Products, 2 Keith 
                                                            
41 ACCC v Marksun Australia Pty Ltd (2011 ATPR ¶42-363 (Gilmour J). 
42 ACCC v Marksun Australia Pty Ltd (2011 ATPR ¶42-363 at [107]. 
43 ACL, s 255. 
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Street Tanunda South Australia 5352” that the products were made in Tanunda, the Barossa 
Valley, or South Australia when in fact they were made by third parties in Victoria and 
Queensland. Maggie Beer Products acknowledged that its conduct was likely to have 
contravened ss 18 and 29(1)(k) of the ACL.  In relation to its investigation the Chairman of 
the ACCC stated: 
Consumers are often willing to pay premium prices for local products and businesses 
are following consumer demand by stocking local goods.  Protecting the integrity of 
credence claims made about food products is a priority enforcement area for the 
ACCC, The Barossa Valley is a nationally recognised premium food and wine 
destination, and businesses in that region use place of origin claims to promote or 
distinguish their product from others in the market. Misleading representations about 
the origin of products to capitalise on this demand undermines the integrity of 
credence claims which are relied on by consumers and, equally important, can harm 
competing producers whose products are made locally.
44
 
This case illustrates the dilemma faced suppliers of food products who wish to register a trade 
mark that incorporates a place of origin, and the business later expands beyond the place of 
origin. If they continue to use the trade mark that contains the place name in relation to products 
produced outside the original place of origin, they likely to contravene ss 18 and 29(1)(k) of the 
ACL; if they cease using the trade mark they lose the value of the goodwill they have developed 
in the brand. 
E Health, therapeutic or safety benefits 
Representations about the superior effectiveness of medical products or treatments are of 
significant concern to the ACCC because of the difficulty of testing the efficacy of the 
product or treatment. A premium health or safety claim may constitute a representation that 
the claim is based on competent and reliable scientific evidence. If there is no significant 
scientific or medical knowledge supporting the claim and it cannot be substantiated, the claim 
is likely to be misleading and may contravene ss 18, 29(1) or 33 of the ACL. For example, in 
ACCC v Reckitt Benckiser (Australia) Pty Ltd (No 4) ,
45
 the Federal Court, by consent, made 
orders that Reckitt Benckiser (RB) had contravened ss 18 and 33 of the ACL by representing 
that each product in the Nurofen Specific Pain Range was specifically formulated to treat the 
particular type of pain specified on the packaging, and the product solely or specifically 
treated the particular type of pain specified on the packaging, namely: 
 Nurofen Migraine Pain in a violet pack; 
 Nurofen Tension Headache in a burgundy pack; 
 Nurofen Period Pain in a magenta pack; and 
 Nurofen Back Pain in a green pack. 
In fact, each product in the Range contained the same active ingredient and was approved on 
the Australian Register of Therapeutic Goods as being suitable for treating a wide variety of 
pain types. It was likely to mislead the public as to the nature, the characteristics or the 
suitability for urpose of the Nurofen Specific Pain Range products. 
                                                            
44 ACCC Media Release 211/14 (19 August 2014). 
45 ACCC v Reckitt Benckiser (Australia) Pty Ltd (No 4) [2015] FCA 1408 (Edelman J). 
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In June 2011 the ACCC, Cancer Council of Australia and the Therapeutic Goods 
Administration issued a joint media release urging Australian women not to rely on unproven 
commercial breast imaging technologies to detect breast cancer.
46
 Since 2011, the ACCC has 
vigorously pursued misleading claims in relation to these technologies. In ACCC v Safe 
Breast Imaging Pty Ltd,
47
 the respondent conducted a breast imaging business using a device 
known as a multi-frequency electrical impedance mammograph (MEM device). The 
respondent made a number of representations, including a representation that the MEM 
device could be used for assessing whether a customer was at risk from breast cancer and the 
level of that risk (the risk of cancer representation), and that imaging with the MEM device 
was a substitute for a breast cancer screening mammogram, such as ultrasound and magnetic 
resonance imaging (the substitute for mammography representation). Barker J found that the 
risk of cancer representation in the promotional materials “…conveyed the representation that 
the MEM device could provide an adequate scientific basis for assessing whether a customer 
was at risk from breast cancer and if so, the level of such risk”.48 As regards the substitute for 
mammography representation Barker J held: 
 
In my view, the overall effect of the promotional materials was that the advertising 
created the erroneous impression that Safe Breast Imaging could provide a 
comparable service to mammography, but without the negative limitations of 
mammography. In my view, a reasonable hypothetical consumer would be led to 
believe that Safe Breast Imaging’s breast imaging is comparable to mammography, 
but without the limitations associated with mammography, and that they could choose 
to have that service as a substitute for mammography.
49
  
A similar claim was made in ACCC v Breast Check Pty Ltd.
50
  
Premium claims in relation to the use of complementary and alternative medicines are also 
likely to be scrutinised carefully by the ACCC to ensure that there is adequate scientific or 
medical evidence to substantiate the claim.
51
 In ACCC v Homeopathy Plus! Australia Pty 
Ltd,
52
 the respondent made representations on its website to the effect that there was a  
reasonable basis, in the sense of an adequate foundation, to enable it to state that its 
homeopathic treatments were a safe and effective alternative treatment to the whooping 
cough vaccine. It was found to have contravened s 18 and s 29(1)(a) of the ACL by 
representing that its homeopathic treatments were of a particular standard or quality, and s 
29(1)(g) of the ACL by representing that its homeopathic treatments had a use or benefit. The 
court found that there was no reasonable basis, in the sense of an adequate foundation, in 
medical science to make such a representation. Perry J stated: 
                                                            
46 See the TGA website at http://www.tga.gov.au/safety/alerts-device-breast-screening-100924.htm 
47 ACCC v Safe Breast Imaging Pty Ltd (2014) ATPR ¶42-464 (Barker J). 
48 ACCC v Safe Breast Imaging Pty Ltd (2014) ATPR ¶42-464 at [68]. 
49 ACCC v Safe Breast Imaging Pty Ltd (2014) ATPR ¶42-464 at [83]. 
50 ACCC v Breast Check Pty Ltd (2014) ATPR ¶42-479.  
51 See Weir M, Wardle, J, Marshall M, and Archer E, “Complementary and alternative medicine and consumer 
law” ((2013) 21(1) Competition & Consumer Law Journal 85. 
52 ACCC v Homeopathy Plus! Australia Pty Ltd [2014] FCA 1412. 
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In line with the lack of published evidence supporting the asserted effectiveness of 
homeopathic treatments for whooping cough, the consensus based on medical science 
is that homeopathic treatments are not an effective alternative to the whooping cough 
vaccine for the prevention of whooping cough.
53
  
Section 29(1)(g) may have a role to play in the area of representations concerning the health 
or safety premium claims for goods. Whether such health and safety benefits constitute 
“performance characteristics” was considered in ACCC v Glendale Chemical Products Pty 
Ltd.
54
 Glendale packaged and sold caustic with a label that stated the product was corrosive 
and contact with eyes and skin should be avoided. It failed to mention the dangers of using 
hot water to dissolve caustic soda. The ACCC unsuccessfully argued at first instance that the 
label represented that the product was safe to use and that this was a performance 
characteristic for the purposes of s 53(c) of the TPA.
55
 On appeal, the Full Federal Court did 
not need to decide the issue having regard to the conclusions reached on other aspects of the 
case, but expressed reservations about the whether the trial Judge’s ruling was correct.56 
Those responsible for making a representation that a product has a health or safety benefit 
must have adequate scientific or medical evidence to substantiate the claim. They must 
carefully qualify the level of safety or any significant risks. For health, therapeutic or safety 
premium claims the ACCC is likely to require a relatively high level of substantiation. 
IV ACCC’s DISCRETIONARY ADMINISTRATIVE POWERS 
A. Substantiation Notices 
The ACCC has two discretionary administrative powers which may be used in relation to 
premium claims for goods. Substantiation notices are likely to be used by the ACCC in 
relation to premium claims where the ACCC cannot readily discern the truth or accuracy of 
the claim being made. For example, in relation to environmental claims, the advertiser is in 
the best position to substantiate a claim that a plastic bag is “biodegradable”,57 or in the case 
food claims, that say eggs are “free range organic”.  
A substantiation notice must be complied with within 21 days of the notice. Providing false 
or misleading information in a substantiation notice gives rise to civil and criminal liability. 
Section 222(1) provides that a person must not provide the regulator false or misleading 
information in compliance or purported compliance with a substantiation notice. 
                                                            
53 ACCC v Homeopathy Plus! Australia Pty Ltd [2014] FCA 1412 at [264]. 
54 ACCC v Glendale Chemical Products Pty Ltd (1998) ATPR ¶41-632.  
55 ACCC v Glendale Chemical Products Pty Ltd (1998) ATPR ¶41-632 at 40,973 (Emmett J).  
56 Glendale Chemical Products Pty Ltd v ACCC (1999) ATPR ¶41-672 at 42, 597 (Wilcox, Tamberlin and 
Sackville JJ). 
57 See the ACCC's Guideline Biodegradable Claims in Advertising is available at 
http://www.accc.gov.au/content/item.phtml?itemId=910298&nodeId=b8fb3f87a088ce8bfd6bfb9e56497a6
5&fn=Biodegradable,%20degradable%20and%20recyclable%20claims%20on%20plastic%20bags.pdf . 
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Part 4-5 of the ACL sets out criminal offence provisions for failing to comply with a 
substantiation notice. Penalties for failing to comply with it within the substantiation notice 
compliance period are $16,500 for a body corporate, and $3,300 for a person who is not a 
body corporate. The ACCC also has extensive evidence gathering powers pursuant to s 155 
of the CCA. For example, in the course of its investigation in ACCC v Safe Breast Imaging 
Pty Ltd,
58
 the company was required pursuant to s 155 to provide details of the published 
clinical trials and scientific research into the efficacy of the MEM device for breast imaging 
in order to establish whether there was a reasonable scientific basis supporting the 
representations made.
59
 
B Infringement Notices 
Infringement notices may be issued by the ACCC relate to past false or misleading premium 
claims. Before issuing an infringement notice, the ACCC will have already formed the view 
that a person has contravened ss 29(1) and/ or 33 of the ACL, and that it is prepared to litigate 
the matter in court for the imposition of a criminal sanction or civil penalty. The ACCC is not 
required to give the company a written statement that sets out ACCC's reasons for believing 
that a contravention has occurred; or give a representative of the company an opportunity to 
make submissions, give evidence and appear at a private hearing before the ACCC; or detail 
the circumstances giving rise to ACCC's reasons to believe a contravention has occurred. 
Since the ACCC will have decided that the matter warrants litigation, a failure to pay an 
infringement notice penalty will likely result in the ACCC commencing proceedings for the 
imposition of a criminal sanction or civil penalty.
60
 
Infringement notices cannot be issued for an alleged contravention of s 18 of the ACL, the 
general misleading or deceptive conduct provision, possibly for the same reason that 
pecuniary penalties cannot be imposed for a contravention of s 18.
61
 Because of its general 
nature it may involve breaches of the law that are unintentional and inadvertent, and it would 
be inappropriate to penalise such conduct. 
If the ACCC has reasonable grounds for believing that a person has contravened an 
infringement notice provision within 12 months after the day on which the contravention is 
alleged to have occurred, the ACCC may issue an infringement notice. If the penalty is paid, 
the matter is closed without proceeding to court. 
Section 134(1) of the CCA provides that the issue of an infringement notice to a person for an 
alleged contravention is “… as an alternative to proceedings for an order under section 224 of 
the Australian Consumer Law”. Thus, the ACCC cannot issue an infringement notice and 
subsequently seek pecuniary penalties in relation to the same alleged contravention. 
Infringement notices carry penalties of $102,000 for ASX-listed corporations, $10,200 for 
bodies corporate other than listed corporations and $2,040 for individuals.
 62
 
                                                            
58 ACCC v Safe Breast Imaging Pty Ltd (2014) ATPR ¶42-464. 
59 ACCC v Safe Breast Imaging Pty Ltd (2014) ATPR ¶42-464 at [135]. 
60 See ACCC, Guidelines on the Use of Infringement Notices (issued on 16 October 2012) at [9]. 
61 CCA, s 134A(2) . 
62 CCA , s 134C . 
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Four examples of infringement notices being issued in relation to premium claims are set out 
below. In 2012, a company paid two infringement notices amounting to $13,000 for labelling 
products as ‘extra virgin olive oil’ when the oil was of inferior quality. There is no mandatory 
standard in Australia for the term ‘extra virgin’ but it is widely accepted to mean oil from the 
first press of the best quality olives.
63
 In March 2015, the Independent Liquor Group (ILG) 
paid a penalty of $10,200 following the issue of an infringement notice by the ACCC in 
relation to the supply of a product named “Aussie beer” and a statement “Made from 
Australia’s finest malt” when in fact the beer was made in China. The ACCC issued the 
infringement notice because it had reasonable grounds for believing that ILG had made a 
false or misleading representation about the country of origin of the product.
64
 In May 2015, 
two companies, Supabarn Supermarkets Pty Ltd and The Real Juice Company Pty Ltd each 
paid penalties of $20,400 following the issue of two infringement notices to each company by 
the ACCC. The ACCC issues the notices because it had reasonable grounds for believing that 
the companies had contravened s 29(1)(a) and 33 of the ACL by making false or misleading 
representations about the composition of apple juice and cranberry juice products. According 
to the ACCC stated that it, 
 
… considered the labelling of the apple juice product made the false or misleading 
representation that the product was made from fresh apples grown in Australia 
through use of the phrases: 
 “It’s produced locally using the freshest quality Apples” 
 “Straight From a Farm” 
 “Made in Griffith” 
when the product was made from reconstituted apple juice concentrate imported from 
China. 
The ACCC considered the labelling of the cranberry juice product made the false or 
misleading representation that the product did not contain added sugar or any other 
additives through use of the phrases: 
 “No added sugar; No artificial flavours; No artificial colours; No 
preservatives” 
 “So if you like your juice fresh with nothing else added” 
 “It’s really just fruit juice!” 
when the product contained added sugar and other additives.
65
 
                                                            
63 ACCC Media release MR 098/12 (18 May 2012). 
64 ACCC Media Release MR 46/15 (30 March 2015). 
65 ACCC Media Release MR 93/15 (28 May 2015). 
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In August 2015, Conroys Pty Ltd paid a penalty of $10,200 in relation to its bacon labelled 
“Product of Australia” when in fact it was produced using imported pig meat.66 On 23 
November 2015, Arnott’s Biscuits Ltd paid penalties of $51,000 in relation to claims that 
Shapes Light & Crispy products had 75 per cent less saturated fat, but the comparison was 
made with potato chips cooked in palm oil rather than original Shapes.
67
 On 26 November 
2015, Cereal Partners Australia Pty Ltd (CPA) paid penalties of $32,400 for false or 
misleading claims concerning the protein content of certain Uncle Tobys brand oats 
products.
68
 
V CIVIL AND CRIMINAL PROCEEDINGS 
In more serious cases the ACCC is likely to apply to the court for the imposition of civil or 
criminal sanctions. The civil prohibitions in ss 29(1)(a) and (g) and  s 33 of the ACL are 
replicated in Chapter 4 of the ACL as criminal offences. Section 151 replicates s 29(1) and s 
155 replicates s 33. The ACCC has a broad authority to enforce the civil prohibitions and 
criminal offences in the ACL.  
The maximum civil pecuniary penalties that can be imposed for each contravention of the 
specific consumer protections provisions (not the general protection in s 18 of the ACL) are 
$1.1 million for a body corporate and $220,000 for persons other than bodies corporate.
69
 The 
matters to be taken into account by the court in assessing an appropriate penalty are set out in 
s 224(2) of the ACL. Where natural persons are knowingly concerned in making false 
premium claims the ACCC will seek to make them liable as accessories pursuant to s 
224(1)(e) of the ACL. 
In addition to pecuniary penalties, the court can order any of the following: 
 declarations;70 
 injunctions to prevent the prohibited conduct from continuing or being repeated;71 
 non-punitive relief for non-party consumers;72 
 non-punitive relief orders, such as for the establishment of a compliance program and 
an order to publish corrective advertising to protect the public interest;
73
 
 orders disqualifying persons from managing a corporation for breaches of the specific 
consumer protection provisions;
74
 and 
                                                            
66 ACCC Media Release MR 150/15 (20 August 2015). 
67 ACCC Media Release, MR 229/15 (23 November 2015). 
68 ACCC Media Release, MR 233/15 (26 November 2015). 
69 ACL, s 224.  
70 Pursuant to s 21 of the Federal Court of Australia Act 1976 (Cth). 
71 ACL, s 232. 
72 ACL, 239(1). 
73 ACL, s 246(1). 
74 ACL, s 248. 
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 court enforceable undertakings.75 
In addition, competitors who have lost business as a result of the misleading premium claims 
may bring proceedings for damages.
76
    
In setting a penalty the courts have regard to the seriousness of the contravention. The 
principal object of imposing a penalty is deterrence, both general and specific.
77
 A penalty of 
$2.5 million was imposed on Coles Supermarkets for is freshly baked bread representations.
78
 
In ACCC v R L Adams Pty Ltd (trading as Darling Downs Fresh Eggs),
79
a penalty of 
$250,000 was imposed for labelling eggs as “free range” and “free to roam” when in fact the 
hens had been continuously confined in two barns that could only be opened with roller 
doors. The hens never had access to the outdoors. In ACCC v Pepe’s Ducks Ltd ,80a penalty 
of $375,000 was imposed on the respondent for making representations that ducks had spent 
a substantial amount of their time outdoors where they were able to forage for food. In ACCC 
v Turi Foods Pty Ltd (No 5),
81
 a penalty of $400,000 was imposed jointly on Baiada and 
Bartter for representations that Steggles chickens were free to roam around in large barns. A 
penalty of $330,000 was imposed on Marksun Australia Pty Ltd in relation to it false Made in 
Australia representations for its Ugg boots.
82
 
In ACCC v Reebok Australia Pty Ltd, Reebok Australia made credence claims regarding its 
Easy Tone shoes for consumers to rely when deciding to purchase the shoes in circumstances 
where the consumers were unable to verify the claims.
83
 As regards the deliberateness of the 
contravening conduct, McKerracher J regarded it as “significant” that Reebok Australia had 
                                                            
75 CCA, s87B. On 19 August 2014, the ACCC terminated its investigation into conduct by Maggie Beer 
Products Pty Ltd, a leading producer of gourmet food products, following the giving of a court 
enforceable undertaking pursuant to s 87B of the CCA. On 2 September 2015, the ACCC accepted s87B 
undertakings from P&M Quality Smallgoods Pty Ltd (trading as Primo Smallgoods, George Weston Foods Pty 
Ltd (trading as KR Castlemaine) and Pastoral Pork Company Pty Ltd (trading as Otway Pork) for use of the 
term “free range” in connection with the promotion and labelling of pork products, when they were not able to 
move about freely in an open paddock. See also the s87B undertaking accepted on 13 June 2014 in which 
Barossa Farm Produce Pty Ltd agreed not to make claims about the characteristics for its Black Pig labelled 
smallgoods when it had no reasonable basis for doing so. See ACCC’s undertakings register at 
http://registers.accc.gov.au/content/index.phtml/itemId/12283 
76 ACL, s 236. 
77 The principles to be applied in assessing penalties in the context of premium claims are discussed in the 
following cases: ACCC v Homeopathy Plus! Australia Pty Ltd (No 2) [2015] FCA 1090 (Perry J); ACCC v 
Coles Supermarkets Australia Pty Limited [2015] FCA 330 (Allsop CJ); ACCC v Safe Breast Imaging Pty Ltd 
(No 2) (2014) ATPR 42-481 (Barker J); ACCC v Breast Check Pty Ltd (No 2) [2014] FCA 1068 (Barker 
J);ACCC v Turi Foods Pty Ltd (No 5) (2013) ATPR ¶42-450 (Tracey J); and ACCC v Marksun Australia Pty Ltd 
(2011 ATPR ¶42-363 (Gilmour J). 
78 ACCC v Coles Supermarkets Australia Pty Limited [2015] FCA 330 (Allsop CJ). 
79 ACCC v R L Adams Pty Ltd (trading as Darling Downs Fresh Eggs) [2015] FCA 2016. 
80 ACCC v Pepe’s Ducks Ltd (2013) ATPR ¶42-441. 
81 ACCC v Turi Foods Pty Ltd (No 5) (2013) ATPR ¶42-450 (Tracey J). 
82 ACCC v Marksun Australia Pty Ltd (2011 ATPR ¶42-363 (Gilmour J). 
83 ACCC v Reebok Australia Pty Ltd [2015] FCA 83 at [69]. 
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continued to import and supply retailers with its shoes and promotional materials containing 
the false representations concerning the toning and strengthening benefits of its shoes despite 
becoming aware that the shoes were the subject of a settlement following enforcement action 
taken by the Federal Trade Commission in the USA against Reebok International. A penalty 
of $350,000 was imposed.
 84
In addition, the Court made an order pursuant to s 239(1) of the 
ACL requiring Reebok to pay the sum of $35 to each consumer who purchased a pair of 
EasyTone shoes from September 2011 to February 2013 and claimed to have to have suffered 
loss or damage as a result of Reebok’s representations.85 
Because of the serious and deliberate nature of the misleading health and therapeutic claims 
in the cases set out above, the ACCC joined the natural persons who were involved in the 
contraventions as accessories. In ACCC v Breast Check Pty Ltd (No 2),
86
Barker J held that: 
“[t]he potential for serious harm to flow from the representations found to have contravened 
the consumer laws, is the key issue”.87 Barker J observed:  
 
The key issue is the potential to divert consumers from using a medically recognised 
form of breast imaging and the harm or potential harm caused by that. Thus, I accept 
that even if only one consumer has been so diverted to their detriment, the 
consequences to a person’s health may be very serious and at worst, fatal.88  
Dr Boyd, by the nature of her involvement in the preparation of the pamphlets, was 
knowingly concerned in the contravention by Breast Check Pty Ltd. However, because of the 
limited period of publication and the limited number of persons to whom the pamphlet was 
distributed, Breast Check was ordered to pay a penalty of $75,000, and Dr Boyd was ordered 
to pay $25,000.
89
 
In ACCC v Safe Breast Imaging Pty Ltd (No 2),
90
 the service was marketed widely through 
the internet. A penalty of $200,000 was imposed on SBI and a penalty of $50,000 on Ms 
Firth who was found to be knowingly concerned in the contraventions of SBI.
91
 In addition, 
the court ordered that Ms Firth be disqualified from managing corporations for a period of 
four years pursuant to s 248 of the ACL.
92
 
                                                            
84 ACCC v Reebok Australia Pty Ltd [2015] FCA 83 at [145]-[147]. 
85 ACCC v Reebok Australia Pty Ltd [2015] FCA 83 at [168]-[170]. 
86 ACCC v Breast Check Pty Ltd (No 2) [2014] FCA 1068. 
87 ACCC v Breast Check Pty Ltd (No 2) [2014] FCA 1068 at [102]. 
88 ACCC v Breast Check Pty Ltd (No 2) [2014] FCA 1068 at [29]-[30]. 
89 ACCC v Breast Check Pty Ltd (No 2) [2014] FCA 1068 at [111]. 
90 ACCC v Safe Breast Imaging Pty Ltd (No 2) (2014) ATPR ¶42-481. 
91 ACCC v Safe Breast Imaging Pty Ltd (No 2) (2014) ATPR ¶42-481 at [77]-[78]. 
92 ACCC v Safe Breast Imaging Pty Ltd (No 2) (2014) ATPR ¶42-481 at [85]. See Knox, M and Seethor, A, 
“Disqualification orders under the Australian Consumer Law” (2015) Australian Journal of Competition and 
Consumer Law 105 
20 | P a g e  
 
Finally, in ACCC v Homeopathy Plus! Australia Pty Ltd (No 2),93 a penalty of $115,000 was 
imposed on Homeopathy Plus! Australia Pty Ltd, and a penalty of $23,000 on its director Ms Frances 
Sheffield. The offending articles were published on the internet in order to promote its online store. In 
setting the penalty, Perry J observed: 
The key issue here, in my view, in considering the significance of loss and damage, is not the 
question of the effect of the conduct on other “competitors”, but the potential to divert 
consumers from immunising themselves and those in their care, with potential risks to their 
health and to the broader community.94 
The ACCC has not yet had recourse to the provisions for the prosecution of the criminal 
offences under Chapter 4 of the ACL. The maximum fines that can be imposed for each 
offence are $1.1 million for a body corporate and $220,000 for persons other than bodies 
corporate. 
VI CONCLUSION 
 
Truth in advertising based on premium claims is a priority enforcement area for the ACCC. 
The test for determining whether a premium claim is misleading is well settled by the High 
Court. The ‘real question’ in a misleading or deceptive conduct case is not the ‘mental state’ 
of the maker of the statement, but the effect of a statement upon its audience — whether the 
statement is apt to mislead those to whom it is published. This in turn will depend on the 
knowledge base attributed to a reasonable member of the target audience. It will be necessary 
to identify precisely what it is that the impugned statements conveyed to a reasonable 
member of the target audience. In the vast majority of cases involving premium claims it will 
not be possible for the maker of the claim to escape liability on the basis that he or she was 
only expressing an opinion and that members of the target audience would be obliged to take 
reasonable care of their own interests, or conduct their own research to test the accuracy of 
the claim before relying on it.
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Many cases involving premium claims will involve information asymmetry, and it will 
simply not be possible for members of the target audience to test the claims. In such 
circumstances, or where the maker of the premium claim is held out as having specialist 
knowledge or expertise, the court may find that a reasonable member of the target audience is 
likely to conclude that the representation conveyed, not merely that the maker believed the 
claim, but also that there were reasonable grounds for that belief, or, in the case of scientific 
or medical claims, that there was an adequate, scientific or medical basis for the claim. If 
there is no adequate basis to substantiate the claim it will be found to be misleading.   
In conducting its investigation into health and therapeutic claims, (and product safety claims) 
the ACCC is likely to use its evidence gathering powers in s 155 of the CCA to require the 
maker of representation to present evidence of the tests or clinical trials that were conducted 
or other evidence relied upon to substantiate the claim. In serious cases involving health and 
therapeutic claims where the potential harm to consumers is great and there is no adequate 
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scientific medical basis for the claim, the ACCC will not hesitate to make those responsible 
for the claims personally liable as accessories. In relation to a country or origin claim a 
supplier will need to retain documentation relating to the costs of ingredients and components 
to ensure that the supplier will be able to provide evidence that 50 per cent or more of the 
total cost of producing or manufacturing the goods took place in that country. 
While proof of intent to convey a premium claim is not necessary for a finding of liability, 
where there is a finding of intention to deceive, the Court may more readily infer that a false 
premium claim is likely to mislead a reasonable member of the target audience. Evidence that 
consumers have been actually been misled is not necessary for a finding of liability. The test 
is an objective one for the court. In serious cases, the ACCC will seek a declaration under s 
21 of the Federal Court of Australia Act 1976 (Cth); an injunction under s 232 of the ACL; 
pecuniary penalties under s 224 of the ACL; refunds for consumers who have suffered loss or 
damage as a result of the misleading premium claims under s 239 of the ACL; and non-
punitive relief orders  for the establishment of a compliance program and the publication of 
corrective advertising under s 264 of the ACL.    
In less serious cases the ACCC makes use substantiation notices and infringement notices in 
an effort to stamp out false or misleading premium claims in the case of minor infringements. 
These discretionary powers are intended to permit initial investigations by the ACCC in a 
greater number of matters, and to deal with matters in a more efficient and cost effective way. 
In addition, as traders become aware of the existence of these administrative powers, they 
will be motivated to take greater care in making claims about the attributes of their products. 
This should result in a higher level of compliance with the ACL. In more serious cases, where 
suppliers deliberately set out to mislead consumers and take market share from their 
competitors, the ACCC will apply to the court for the imposition of civil pecuniary penalties 
and other orders, including corrective advertising, and disqualification from managing 
corporations. Those contemplating the use of premium claims to differentiate their products 
from those of their competitors will need to think carefully about the accuracy of the claims 
and whether they can substantiate them before they are disseminated.  
  
 
